Biopharmaceutical products, such as monoclonal antibodies (mAbs), demonstrate promise in treating many diseases and disorders . Developing antibody drugs need a proper formulation to stabilize the biopharmaceutical products, which requires knowledge of proteins and small molecules as excipients for formulation development . Because of the high cost of mAbs production, computer modeling, and simulation tools are desirable to facilitate formulation design .